BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 37809638)

  • 1. Estrogens and the risk of breast cancer: A narrative review of literature.
    Al-Shami K; Awadi S; Khamees A; Alsheikh AM; Al-Sharif S; Ala' Bereshy R; Al-Eitan SF; Banikhaled SH; Al-Qudimat AR; Al-Zoubi RM; Al Zoubi MS
    Heliyon; 2023 Sep; 9(9):e20224. PubMed ID: 37809638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High progesterone receptor concentration in a variant of the ZR-75-1 human breast cancer cell line adapted to growth in oestrogen free conditions.
    van den Berg HW; Martin J; Lynch M
    Br J Cancer; 1990 Apr; 61(4):504-7. PubMed ID: 2139575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biology of female sex hormone action in relation to contraceptive agents and neoplasia.
    King RJ
    Contraception; 1991 Jun; 43(6):527-42. PubMed ID: 1651204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The menopause: benefits and risks of estrogen-progestogen replacement therapy.
    Gambrell RD
    Fertil Steril; 1982 Apr; 37(4):457-74. PubMed ID: 7040116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogens and breast cancer: present position.
    Hawkins RA
    Scott Med J; 1980 Apr; 25(2):152-7. PubMed ID: 7455674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential benefits of estrogens and progestogens on breast cancer.
    Schneider HP; Jackisch C
    Int J Fertil Womens Med; 1998; 43(6):278-85. PubMed ID: 9920536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk.
    Pike MC; Spicer DV; Dahmoush L; Press MF
    Epidemiol Rev; 1993; 15(1):17-35. PubMed ID: 8405201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A biological marker, strongly associated with early oral contraceptive use, for the selection of a high risk group for premenopausal breast cancer.
    Olsson H; Borg A; Ewers SB; Fernö M; Möller T; Ranstam J
    Med Oncol Tumor Pharmacother; 1986; 3(2):77-81. PubMed ID: 3747639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical significance of analysis of estrogen and progesterone receptors in human uterine tissues].
    Maleeva A; Milkov V
    Akush Ginekol (Mosk); 1991 May; (5):55-7. PubMed ID: 1897675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism of estrogens in breast cancer.
    Dao TL
    Biochim Biophys Acta; 1979 Dec; 560(4):397-426. PubMed ID: 391284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of estrogens and progesterone in the etiology and prevention of endometrial cancer: review.
    Gambrell RD; Bagnell CA; Greenblatt RB
    Am J Obstet Gynecol; 1983 Jul; 146(6):696-707. PubMed ID: 6307050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen replacement therapy: indications and complications.
    Judd HL; Meldrum DR; Deftos LJ; Henderson BE
    Ann Intern Med; 1983 Feb; 98(2):195-205. PubMed ID: 6824255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormones and hormone antagonists: mechanisms of action in carcinogenesis of endometrial and breast cancer.
    Flötotto T; Djahansouzi S; Gläser M; Hanstein B; Niederacher D; Brumm C; Beckmann MW
    Horm Metab Res; 2001 Aug; 33(8):451-7. PubMed ID: 11544557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of hormone carcinogenesis: evolution of views, role of mitochondria.
    Chen JQ; Brown TR; Yager JD
    Adv Exp Med Biol; 2008; 630():1-18. PubMed ID: 18637481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of estrogen and progesterone receptors and estrogen metabolizing enzymes in different breast cancer cell lines.
    Hevir N; Trošt N; Debeljak N; Rižner TL
    Chem Biol Interact; 2011 May; 191(1-3):206-16. PubMed ID: 21182832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Estrogen intracrinology: therapy and chemoprevention of breast cancer].
    Licznerska B; Baer-Dubowska W
    Postepy Hig Med Dosw (Online); 2010 May; 64():220-30. PubMed ID: 20498499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and Role of the G Protein-Coupled Estrogen Receptor (GPR30/GPER) in the Development and Immune Response in Female Reproductive Cancers.
    Hernández-Silva CD; Villegas-Pineda JC; Pereira-Suárez AL
    Front Endocrinol (Lausanne); 2020; 11():544. PubMed ID: 32973677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen metabolism and risk of breast cancer in postmenopausal women.
    Fuhrman BJ; Schairer C; Gail MH; Boyd-Morin J; Xu X; Sue LY; Buys SS; Isaacs C; Keefer LK; Veenstra TD; Berg CD; Hoover RN; Ziegler RG
    J Natl Cancer Inst; 2012 Feb; 104(4):326-39. PubMed ID: 22232133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen and its metabolites are carcinogenic agents in human breast epithelial cells.
    Russo J; Hasan Lareef M; Balogh G; Guo S; Russo IH
    J Steroid Biochem Mol Biol; 2003 Oct; 87(1):1-25. PubMed ID: 14630087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Editorial: Hormone receptors and breast cancer.
    Br Med J; 1976 Jul; 2(6027):67-8. PubMed ID: 179660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.